Vitamin Shoppe (VSI) Tops Q1 EPS by 1c, Beats on Revenues

Vitamin Shoppe (NYSE: VSI) reported Q1 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $295.96 million versus the consensus estimate of $298.92 million.

First Quarter 2018 Highlights:

• Total Comparable Sales (3.6%)
• Digital commerce increases 20.7%
• Repurchases $45 million face value of convertible debt at a discount
• GAAP loss per share of $0.17, impacted by loss from discontinued operations, partially offset by gain on debt extinguishment.
• Adjusted earnings per share (EPS) from continuing operations of $0.10.

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c